Search

Your search keyword '"Lawrence, Michael S."' showing total 1,059 results

Search Constraints

Start Over You searched for: Author "Lawrence, Michael S." Remove constraint Author: "Lawrence, Michael S."
1,059 results on '"Lawrence, Michael S."'

Search Results

152. Complementary genomic approaches highlight the P13K/mTOR pathway as a common vulnerability in osteosarcoma

153. Multi-Omics Profiling of Longitudinal Samples Reveals Early Genomic Changes in Follicular Lymphoma

155. Chromatin-bound RB targets promoters, enhancers, and CTCF-bound loci and is redistributed by cell-cycle progression

156. Abstract 657: Impact of therapy induced APOBEC3A mutagenesis on tumor evolution in non small cell lung cancer

157. YAP1 maintains active chromatin state in head and neck squamous cell carcinomas that promotes tumorigenesis through cooperation with BRD4

158. Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1

159. Pathway and network analysis of more than 2500 whole cancer genomes

160. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes

161. Integrated genomic characterization of oesophageal carcinoma

162. Cell-of-origin chromatin organization shapes the mutational landscape of cancer

163. Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2

164. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

165. Translesion DNA synthesis mediates acquired resistance to olaparib plus temozolomide in small cell lung cancer

168. Differential Kinase Activity Across Prostate Tumor Compartments Defines Sensitivity to Target Inhibition

169. The Mutational Landscape of Head and Neck Squamous Cell Carcinoma

170. Supplement to: Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas.

171. Therapy-induced APOBEC3A drives evolution of persistent cancer cells

172. Active RB causes visible changes in nuclear organization

173. Antibody-Peptide Epitope Conjugates for Personalized Cancer Therapy

174. Discovery and saturation analysis of cancer genes across 21 tumour types

175. NR4A1 regulates expression of immediate early genes, suppressing replication stress in cancer

178. APOBEC Mutagenesis Is Concordant between Tumor and Viral Genomes in HPV-Positive Head and Neck Squamous Cell Carcinoma

181. Dissection of PIK3CA Aberration for Cervical Adenocarcinoma Outcomes

182. RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast Cancer

183. An extended APOBEC3A mutation signature in cancer.

184. A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers

185. Sequence analysis of mutations and translocations across breast cancer subtypes

186. Huge whole-genome study of human metastatic cancers

187. Comprehensive molecular characterization of urothelial bladder carcinoma

188. Landscape of genomic alterations in cervical carcinomas

190. An extended APOBEC3A mutation signature in cancer

191. Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in ROS1 Fusion–Positive Lung Cancer

192. Somatic mutations affect key pathways in lung adenocarcinoma

193. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes

194. Analyses of non-coding somatic drivers in 2,658cancer whole genomes

195. Recurrent and functional regulatory mutations in breast cancer

196. Pathway and network analysis of more than 2500 whole cancer genomes.

197. Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis

198. Quantification of ongoing APOBEC3A activity in tumor cells by monitoring RNA editing at hotspots.

199. Pathway and network analysis of more than 2500 whole cancer genomes

200. Pan-cancer analysis of whole genomes

Catalog

Books, media, physical & digital resources